Lubrizol LifeSciences adds commercial manufacturing capacity at Particle Sciences

The Lubrizol Corporation’s LifeSciences, the leading contract development and manufacturing organization (CDMO) for complex drug products, is adding commercial drug product manufacturing capacity at its Particle Sciences facility in Bethlehem, PA. The 18,000 square foot capacity will include both sterile and non-sterile space with complete lyophilization and filling operations.  Among other things, the facility will

BIOCORP accelerates its business development

BIOCORP, a French company specializing in the development and manufacturing of innovative medical and drug delivery devices, announced today the acceleration of its connected devices developments in collaboration with several international pharmaceutical laboratories enhancing therefore Its expertise in e-health via two connected devices: DataPen and Easylog. “These latest developments confirm the relevance of our strategy based on breakthrough technologies as illustrated by the development of

Futurist Ray Kurzweil predicts printed organs, nanorobots, and connecting our brains to computers in the cloud

Futurist Ray Kurzweil made a thought-provoking presentation at the recent MD&M in Anaheim, a trade show for medical device companies. His presentation dealt with the accelerating rate of technical progress, predicting the future, and the human life span. Let’s start with one of his discoveries, that the technical future is predictable and with good precision,

Laser surgery opens blood-brain barrier to chemotherapy

Using a laser probe, neurosurgeons at Washington University School of Medicine in St. Louis have opened the brain’s protective cover, enabling them to deliver chemotherapy drugs to patients with a form of deadly brain cancer. In a pilot study, 14 patients with glioblastoma—the most common and aggressive type of brain cancer—underwent minimally invasive laser surgery

ScandiDos obtains FDA 510(k) for Delta4 Discover in U.S.

ScandiDos announced that Delta4 Discover received 510(k) clearance by the U.S. Food and Drug Administration, bringing to market the first device that independently verifies the radiation dose delivered to a patient during radiation treatment. “Until now, the concept of measuring the daily dose of radiation in real time, to ensure it accurately matches the patient

Biocorp appoints Robert Kilgore as Senior Advisor to build its presence in the United States

Biocorp, a French company specializing in the development and manufacturing of innovative medical and drug delivery devices, announces the appointment of Robert Kilgore as Senior Advisor. “We are thrilled to announce the appointment of Robert Kilgore within our company as a Senior Advisor. Robert is a well-known expert in the medical community. His previous senior positions

Stainless steel construction meets strict industry requirements

Reduction Engineering Scheer introduced a new line of fully pharmaceutical-grade strand pelletizers, which are used in applications where pharmaceutical drugs are mixed with active ingredients in an extruder. Reduction Engineering sees increased demand from the pharmaceutical industry for these pelletizer systems and has entered the market. The pharma-grade pelletizers are targeted for applications that must

How do you keep vaccines cool? Try spacecraft insulation

By Sophie Cousins, NPR If you’ve ever been vaccinated, you may have seen the nurse head out of the room to go to the refrigerator to retrieve your injection. That’s because most vaccines must be refrigerated during travel and storage or they lose their effectiveness. Vaccines typically need what’s known as a “cold chain.” From

B. Braun gets into managed care with First Databank

B. Braun Medical said yesterday it will offer clinical support and managed care resources for and infusion pump drug library through a collaboration with First Databank. Bethlehem, Penn.-based B. Braun said it will be the 1st implementation of an infusion pump drug library with FDB. “Our innovative drug library software furthers our commitment to reducing medication

Simulating the release mechanism in drug-eluting stents

Simulations of drug-eluting stents by engineers at Boston Scientific provide an understanding of the drug-release mechanism by tying experimental findings to a computational model. Lexi Carver, Comsol, Inc Contributing authors: Travis Schauer and Ismail Guler, Boston Scientific Corp Treating arteries in the heart that have been blocked by plaque is a common challenge for medical

Using ultrasound to improve drug delivery

Using ultrasound waves, researchers from MIT and Massachusetts General Hospital (MGH) have found a way to enable ultra-rapid delivery of drugs to the gastrointestinal (GI) tract. This approach could make it easier to deliver drugs to patients suffering from GI disorders such as inflammatory bowel disease, ulcerative colitis, and Crohn’s disease, the researchers say. Currently,

Nanobots: The rise of the molecular machines

Nanomachines – including nano-sized motors, rockets and even cars – are many orders of magnitude smaller than a human cell, but they have huge promise. In the future, they could deliver drugs anywhere in the body, clean up oil spills and might even be used as artificial muscle cells. Find out more about these molecular

Motors make spectrophotometer foolproof

Mike LeBlanc / Applications Engineer / MICROMO Scientists working in genomics and proteomics need results at the touch of a button, so they can set about their real work: drug discovery, advanced diagnostics and understanding the stuff of life. When DeNovix set out to develop a spectrophotometer for life science analysis, they focused on designing

Securing mobile medical equipment with electronic access

Steve Spatig / General Manager of Electronic Access Solutions / Southco In modern medical practice, efficiency is key. Newer technologies allow for the mobility of medical equipment, letting personnel bring medical supplies and machines closer to patients, whether they are in the emergency room or an emergency vehicle. But with this improved accessibility, how can

Mott Corporation develops ultra-low flow technology for drug delivery

Mott Corporation has developed a technology that controls the flow rate of a liquid or drug in devices over extended periods of time. This technology can be configured for passive or diffusional flow and can also manage flow rates in powered devices. When used for diffusional flow, Mott’s porous metal components can be configured to